Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
2004 1
2005 2
2007 1
2008 2
2012 1
2013 1
2018 1
2019 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Small cell carcinoma of the stomach: A report of two cases and a review of the literature.
Bakogeorgos M, Kalkanis D, Katsaounis P, Ramfidis V, Speliades C, Pierrakou E, Papadopoulos S, Pantazopoulos N, Georgoulias V, Kotsakis A, Kentepozidis N. Bakogeorgos M, et al. Among authors: pantazopoulos n. Mol Clin Oncol. 2018 Jul;9(1):11-16. doi: 10.3892/mco.2018.1624. Epub 2018 May 10. Mol Clin Oncol. 2018. PMID: 29896397 Free PMC article.
MINOAS: A Single-arm Translational Phase II Trial of FOLFIRI Plus Aflibercept as First-line Therapy in Unresectable, Metastatic Colorectal Cancer.
Matikas A, Souglakos J, Katsaounis P, Kotsakis A, Kouroupakis P, Pantazopoulos N, Kentepozidis N, Nikolaidi A, Messaritakis I, Tzovara I, Hatzidaki D, Prinarakis E, Georgoulias V. Matikas A, et al. Among authors: pantazopoulos n. Target Oncol. 2019 Jun;14(3):285-293. doi: 10.1007/s11523-019-00647-3. Target Oncol. 2019. PMID: 31203498 Clinical Trial.
A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group.
Kontopodis E, Hatzidaki D, Varthalitis I, Kentepozidis N, Giassas S, Pantazopoulos N, Vardakis N, Rovithi M, Georgoulias V, Agelaki S. Kontopodis E, et al. Among authors: pantazopoulos n. J Chemother. 2013 Feb;25(1):49-55. doi: 10.1179/1973947812Y.0000000050. J Chemother. 2013. PMID: 23433445 Clinical Trial.
Paclitaxel in combination with carboplatin as salvage treatment in patients with castration-resistant prostate cancer: a Hellenic oncology research group multicenter phase II study.
Kentepozidis N, Soultati A, Giassas S, Vardakis N, Kalykaki A, Kotsakis A, Papadimitraki E, Pantazopoulos N, Bozionellou V, Georgoulias V. Kentepozidis N, et al. Among authors: pantazopoulos n. Cancer Chemother Pharmacol. 2012 Jul;70(1):161-8. doi: 10.1007/s00280-012-1896-9. Epub 2012 Jun 3. Cancer Chemother Pharmacol. 2012. PMID: 22660737 Clinical Trial.
Infections in children with acute leukemia.
Freeman AI, Pantazopoulos N, DeCastro L, Sinks LF. Freeman AI, et al. Among authors: pantazopoulos n. Med Pediatr Oncol. 1975;1(2):67-73. doi: 10.1002/mpo.2950010212. Med Pediatr Oncol. 1975. PMID: 778573
11 results